Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2971444 | The Journal of Heart and Lung Transplantation | 2011 | 8 Pages |
Abstract
Basiliximab prior to implant is associated with a lower cumulative acute rejection score over 1 year compared with induction post-implantation. Despite a lower cumulative acute rejection score, there was no significant difference in freedom from BOS or survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rajeev MD, Lisa L. MD, Hassan W. MD, Lisa D. DO, Alan D. MD,